Table 3.
Effect of dietary treatments on the ileal histomorphology on day 35 of age.
Items | Experimental treatments | SEM | p | ||||||
---|---|---|---|---|---|---|---|---|---|
NC | Microencapsulated | Non-microencapsulated | |||||||
OA | EO | OA+EO | OA | EO | OA+EO | ||||
VH | 607.8b | 742.7a | 720.6ab | 754.8a | 639.3ab | 657.6ab | 628.1ab | 28.32 | 0.040 |
CD | 81.3ab | 66.6c | 64.6c | 64.0c | 82.9ab | 76.9b | 86.1a | 2.45 | <0.001 |
VH:CD | 7.5b | 11.1a | 11.2a | 11.8a | 7.8b | 8.6b | 7.3b | 0.42 | <0.001 |
Goblet cells/100 μm VH | 27.7a | 14.1b | 15.4b | 16.1b | 24.3a | 23.5a | 26.0a | 0.67 | <0.001 |
NC, negative control; OA, organic acid: fumaric; EO, essential oil: thymol.
Inclusion levels: microencapsulated fumaric acid: 1.5 g/kg; microencapsulated thymol: 3 g/kg; non-microencapsulated fumaric acid: 0.9 g/kg; non-microencapsulated thymol: 0.6 g/kg.
Different letters indicate significant difference between the seven dietary treatments at p ≤ 0.05.
Data are presented as mean (n = 10 replicates/group for all evaluated parameters).